CVS Caremark (CVS) Tops Q4 EPS by 4c; Guides FY13 In-Line

February 6, 2013 7:02 AM EST
CVS Caremark (NYSE: CVS) reported Q4 EPS of $1.14, $0.04 better than the analyst estimate of $1.10. Revenue for the quarter came in at $31.4 billion versus the consensus estimate of $31.13 billion.

CVS Caremark sees FY2013 EPS of $3.86-4.00, versus the consensus of $3.94.

For earnings history and earnings-related data on CVS Caremark (CVS) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance, Hot Earnings

Related Entities


Add Your Comment